Rapid point-of-care (POC) testing for Hepatitis C antibodies in a very high prevalence setting: persons injecting drugs in Tallinn, Estonia

Between December 2018 and January of 2019, we evaluated the accuracy of the point-of-care Hepatitis C (HCV) antibody test (POC; OraQuick HCV) used at a community-based needle and syringe exchange program servi...

Source: Harm Reduction Journal - April 1, 2021 Category: Drugs & Pharmacology Authors: Anneli Uusk üla, Ave Talu, Jürgen Rannap, David M. Barnes and Don Des Jarlais Tags: Research Source Type: research